Latest data from May 6, 2022
Number of Health Center respondents = 17 (63% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics |
Value |
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 |
1,738 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) |
47.58% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 |
155 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) |
41.43% |
Patients by Race and Ethnicity
Race/Ethnicity |
Patients Tested, Virus Detection (PCR, Antigen)2 |
Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
White, Non-Hispanic/Latino Patients |
46.03% |
52.90% |
White, Hispanic/Latino Patients |
15.19% |
18.71% |
Black/African American, Non-Hispanic/Latino Patients |
16.11% |
13.55% |
Black/African American, Hispanic/Latino Patients |
0.35% |
0.00% |
Asian Patients3 |
4.32% |
0.00% |
American Indian/Alaska Native Patients3 |
0.17% |
0.00% |
Native Hawaiian/Other Pacific Islander Patients3 |
0.17% |
0.00% |
Patients with More Than One Race3 |
1.50% |
1.29% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
3.97% |
3.87% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
1.67% |
1.29% |
Unreported/Refused to Report Race and Ethnicity |
10.53% |
8.39% |
Patients Vaccinated
Metrics |
Value |
COVID-19 Immunization Series Initiated |
410 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization |
71.17% |
COVID-19 Immunization Series Completed |
528 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization |
61.07% |
COVID-19 Immunization Series Additional |
803 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine |
62.47% |
Vaccinations by Race and Ethnicity
Race/Ethnicity |
Patient COVID-19 Immunization Series Initiated2 |
Patient COVID-19 Immunization Series Completed2 |
Patient COVID-19 Immunization Series Additional2 |
White, Non-Hispanic/Latino Patients |
27.56% |
35.98% |
37.11% |
White, Hispanic/Latino Patients |
23.41% |
13.64% |
12.95% |
Black/African American, Non-Hispanic/Latino Patients |
23.66% |
17.61% |
27.52% |
Black/African American, Hispanic/Latino Patients |
0.49% |
0.57% |
0.37% |
Asian Patients3 |
2.68% |
4.36% |
1.99% |
American Indian/Alaska Native Patients3 |
0.00% |
0.38% |
1.00% |
Native Hawaiian/Other Pacific Islander Patients3 |
0.24% |
1.89% |
0.62% |
Patients with More Than One Race3 |
5.37% |
3.41% |
4.23% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
12.20% |
14.58% |
13.08% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.73% |
1.70% |
0.75% |
Unreported/Refused to Report Race and Ethnicity |
3.66% |
5.87% |
0.37% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics |
Value |
Less Than 1 Hour |
35.29% |
1 to 24 Hours |
29.41% |
More Than 24 Hours |
29.41% |
N/A |
5.88% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics |
Value |
Financial reimbursement for costs associated with vaccine administration |
5.88% |
Staffing to administer the vaccine |
29.41% |
Vaccine confidence |
47.06% |
Vaccine storage capacity |
5.88% |
Vaccine supply |
0.00% |
Other |
11.76% |
None |
29.41% |
Operations and Staff
Metrics |
Value |
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program |
29.41% |
Average Percent of Health Center Visits Conducted Virtually |
7.06% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics |
Value |
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics |
23.53% |
Number of Mobile Van Sites |
0 |
Number of Pop-up Clinics |
15 |
Number of School-Based Vaccination Sites |
0 |
Number of Family Vaccination Clinics |
28 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics |
Value |
Direct provision of monoclonal antibody therapies |
5.88% |
Refer patients to another organization that provides monoclonal antibody therapies |
52.94% |
None |
41.18% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics |
Value |
Access to therapeutics |
11.76% |
Patient awareness/education |
5.88% |
Staffing capacity |
17.65% |
Therapy administration/onsite logistics |
17.65% |
Other |
5.88% |
None |
58.82% |
Test Kit Distribution
Metrics |
Value |
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program |
12 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program |
7,732 |
Test Kit Distribution Methods4
Metrics |
Value |
Provided to Existing Health Center Patients |
83.33% |
Provided to General Public Who Came to the Health Center |
50.00% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) |
16.67% |
Provided at Other Community Events |
58.33% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals |
8.33% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals |
8.33% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals |
16.67% |
Provided to school-age children and/or their families directly or through partnerships with schools |
16.67% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities |
16.67% |
Other |
8.33% |
N95 Mask Distribution
Metrics |
Value |
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program |
9 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program |
2,623 |
N95 Mask Distribution Methods5
Metrics |
Value |
Provided to Existing Health Center Patients |
77.78% |
Provided to General Public Who Came to the Health Center |
66.67% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) |
22.22% |
Provided at Other Community Events |
44.44% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals |
0.00% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals |
11.11% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals |
22.22% |
Provided to school-age children and/or their families directly or through partnerships with schools |
33.33% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities |
0.00% |
Other |
11.11% |
Oral Antiviral Medication Distribution
Metrics |
Value |
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program |
1 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication |
8.33% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity |
Value |
White, Non-Hispanic/Latino Patients |
83.33% |
White, Hispanic/Latino Patients |
0.00%
|
Black/African American, Non-Hispanic/Latino Patients |
0.00%
|
Black/African American, Hispanic/Latino Patients |
0.00% |
Asian Patients3 |
0.00% |
American Indian/Alaska Native Patients3 |
8.33% |
Native Hawaiian/Other Pacific Islander Patients3 |
0.00% |
Patients with More Than One Race3 |
0.00%
|
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.00% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.00% |
Unreported/Refused to Report Race and Ethnicity |
8.33% |
Oral Antiviral Medication Distribution by Population Type
Metrics |
Value |
Migratory/Agricultural Workers |
0.00% |
Patients Experiencing Homelessness |
0.00% |
Patients Who Are Residents of Public Housing |
0.00% |
Patients with Limited English Proficiency |
0.00% |
Children Under 18 Years of Age |
0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.